Sarcopenia in Acute Ischemic Stroke
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age50+
SponsorUniversity Clinical Hospital na V.V.Vinogradov (branch of RUDN university na Patrice Lumumba)
About this trial
The objective of this observational study is to determine the prevalence of sarcopenia in patients aged 50 years and older with acute ischemic stroke, to characterize its trajectory during the acute phase using instrumental verification and functional-cognitive assessments, and to evaluate its impact on functional outcome at three months. The main research question is:
Is the presence of sarcopenia at admission associated with less favorable stroke outcomes, including higher rates of complications and mortality?
Participants receiving standard medical care for acute ischemic stroke will undergo extended functional assessment for sarcopenia, and a subset will additionally undergo cognitive evaluation.
Eligibility criteria
Qualifiers
Age 50 years and older
Acute ischemic stroke confirmed by CT or MRI
Admission within the first 72 hours
Written informed consent and availability of a contact telephone number for follow-up
Disqualifiers
TIA without a visible lesion on neuroimaging; bilateral hemiparesis
Amputations or severe contractures that preclude anthropometric assessment
Active cancer at stage IV or life expectancy of less than 3 months
Neuromuscular diseases; chronic use of systemic glucocorticoids for more than 3 months
Trial design
Treatments tested in this trial
- Not listed
Trial groups
No trial groups listed
Sponsors and collaborators
Source ClinicalTrials.gov